drugset
drugset / Trial / NCT03444818

A Study to Determine the Absorption, Metabolism, and Excretion of [14C]-E6007 After a Single Oral Administration in Healthy Male Participants

NCT03444818 ↗

Phase 1 Completed 6 enrolled EA Pharma Co., Ltd.
NaSingle-groupOpen-labelBasic science

Summary

This study will be conducted to evaluate the absorption, metabolism, and excretion of a single oral dose of \[14C\]-E6007 in healthy male participants.

Timeline

Start
2018-04-17
Primary completion
2018-06-26
Completion
2018-06-26

Drugs

EvaluationDrugModalityDoseRoute
Subject E6007 Unknown 60 mg Oral

Indications

No indication recorded.